Stallergenes Greer plc – Strategy, SWOT and Corporate Finance Report
- Pages: 82
- Published: December 2018
- Report Code: MLPH2508812FSA
Stallergenes Greer plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Stallergenes Greer plc (Stallergenes Greer), formerly Ares Allergy Holdings plc is a biopharmaceutical company, which provides treatments for allergy-related respiratory diseases. The company develops diagnostic tests and products with principal focus on allergies. The company offers treatment for important respiratory diseases, which include severe rhino conjunctivitis and rhinitis, and allergic asthma. Stallergenes Greer provides allergen immunotherapy in various dosage forms including injectable or subcutaneous injections, liquid sublinguals and solid sublinguals. Its research and development activities involve development of candidate products, laboratory research, clinical development and regulatory activities. The company distributes its products to various countries in North America, Europe, Africa; Asia and in Australia. Stallergenes Greer is headquartered in London, the UK.
Scope
Detailed information on Stallergenes Greer plc required for business and competitor intelligence needs
A study of the major internal and external factors affecting Stallergenes Greer plc in the form of a SWOT analysis
An in-depth view of the business model of Stallergenes Greer plc including a breakdown and examination of key business segments
News about Stallergenes Greer plc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Stallergenes Greer plc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Stallergenes Greer plc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Stallergenes Greer plcs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
UCB SA
Meda Pharmaceuticals Inc
Perrigo Company Plc
GlaxoSmithKline Plc
Sanofi
Merck KGaA
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.